loading
前日終値:
$54.14
開ける:
$54.62
24時間の取引高:
16,482
Relative Volume:
0.05
時価総額:
$2.19B
収益:
-
当期純損益:
$-168.05M
株価収益率:
-11.84
EPS:
-4.54
ネットキャッシュフロー:
$-146.15M
1週間 パフォーマンス:
-10.75%
1か月 パフォーマンス:
-10.67%
6か月 パフォーマンス:
+6.81%
1年 パフォーマンス:
+74.66%
1日の値動き範囲:
Value
$53.09
$54.62
1週間の範囲:
Value
$52.63
$60.58
52週間の値動き範囲:
Value
$27.31
$73.00

Keros Therapeutics Inc Stock (KROS) Company Profile

Name
名前
Keros Therapeutics Inc
Name
セクター
Healthcare (1195)
Name
電話
617-314-6297
Name
住所
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
Name
職員
160
Name
Twitter
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
KROS's Discussions on Twitter

KROS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
KROS 53.85 2.19B 0 -168.05M -146.15M -4.54
VRTX 446.35 115.74B 10.63B -479.80M -1.35B 13.33
REGN 740.93 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.43 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.82 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.80 24.49B 3.30B -501.07M 1.03B 11.54

Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-02-21 開始されました William Blair Outperform
2023-12-08 開始されました Wells Fargo Overweight
2023-07-31 開始されました Wedbush Outperform
2023-07-26 開始されました BofA Securities Buy
2023-02-14 開始されました Cowen Outperform
2022-10-18 開始されました Truist Buy
2022-07-26 開始されました BTIG Research Buy
2020-12-08 繰り返されました H.C. Wainwright Buy
2020-05-04 開始されました H.C. Wainwright Buy
2020-05-04 開始されました Jefferies Buy
2020-05-04 開始されました Piper Sandler Overweight
2020-05-04 開始されました SVB Leerink Outperform
すべてを表示

Keros Therapeutics Inc (KROS) 最新ニュース

pulisher
Nov 16, 2024

Long Term Trading Analysis for (KROS) - Stock Traders Daily

Nov 16, 2024
pulisher
Nov 11, 2024

What is Leerink Partnrs’ Estimate for KROS FY2024 Earnings? - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Equities Analysts Offer Predictions for KROS FY2024 Earnings - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

What is HC Wainwright's Estimate for KROS FY2024 Earnings? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Wedbush Decreases Earnings Estimates for Keros Therapeutics - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

William Blair Issues Pessimistic Forecast for KROS Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Leerink Partnrs Has Negative Outlook of KROS FY2024 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Wedbush Equities Analysts Cut Earnings Estimates for KROS - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

FY2024 Earnings Estimate for KROS Issued By HC Wainwright - Defense World

Nov 11, 2024
pulisher
Nov 09, 2024

Keros Therapeutics (NASDAQ:KROS) Now Covered by Jefferies Financial Group - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

Keros Therapeutics Third Quarter 2024 Earnings: US$1.41 loss per share (vs US$1.33 loss in 3Q 2023) - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Brokers Offer Predictions for KROS Q3 Earnings - Defense World

Nov 08, 2024
pulisher
Nov 07, 2024

Q3 Earnings Estimate for KROS Issued By Wedbush - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Interesting KROS Put And Call Options For April 2025 - Nasdaq

Nov 07, 2024
pulisher
Nov 07, 2024

HC Wainwright Reaffirms Buy Rating for Keros Therapeutics (NASDAQ:KROS) - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Brokers Set Expectations for KROS Q4 Earnings - Defense World

Nov 07, 2024
pulisher
Nov 06, 2024

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results - GlobeNewswire

Nov 06, 2024
pulisher
Nov 06, 2024

KROSKeros Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Keros Therapeutics to Present at Guggenheim Conference - TipRanks

Nov 06, 2024
pulisher
Nov 06, 2024

Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Brokers Issue Forecasts for KROS Q4 Earnings - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Wedbush Upgrades Keros Therapeutics (NASDAQ:KROS) to Strong-Buy - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition - GlobeNewswire

Nov 06, 2024
pulisher
Nov 05, 2024

Jefferies starts Keros Therapeutics with buy, $107 target By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

(KROS) Proactive Strategies - Stock Traders Daily

Nov 05, 2024
pulisher
Nov 05, 2024

Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Nov 05, 2024
pulisher
Nov 03, 2024

Emerald Advisers LLC Acquires Shares of 155,545 Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Nov 03, 2024
pulisher
Nov 01, 2024

Brokerages Set Keros Therapeutics, Inc. (NASDAQ:KROS) PT at $89.11 - Defense World

Nov 01, 2024
pulisher
Oct 30, 2024

Keros Therapeutics, Inc. (NASDAQ:KROS) Short Interest Update - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Analysts Offer Predictions for KROS FY2024 Earnings - Defense World

Oct 29, 2024
pulisher
Oct 28, 2024

Assenagon Asset Management S.A. Boosts Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Cantor Fitzgerald Weighs in on KROS FY2024 Earnings - Defense World

Oct 28, 2024
pulisher
Oct 28, 2024

Brokers Set Expectations for KROS FY2024 Earnings - MarketBeat

Oct 28, 2024
pulisher
Oct 26, 2024

Keros Therapeutics (NASDAQ:KROS) Now Covered by Cantor Fitzgerald - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

(KROS) Trading Signals - Stock Traders Daily

Oct 25, 2024
pulisher
Oct 25, 2024

Cantor Fitzgerald initiates coverage on Keros Therapeutics shares with Overweight rating - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Cantor Fitzgerald initiates coverage on Keros Therapeutics shares with Overweight rating By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Cantor Fitzgerald Initiates Coverage on Keros Therapeutics (NASDAQ:KROS) - MarketBeat

Oct 24, 2024
pulisher
Oct 16, 2024

Keros Therapeutics (NASDAQ:KROS) Now Covered by Scotiabank - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics appoints new Chief Medical Officer - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer - GlobeNewswire

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics appoints new Chief Medical Officer By Investing.com - Investing.com UK

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics, Inc. Appoints Yung H. Chyung as Chief Medical Officer, Effective as of November 1, 2024 - Marketscreener.com

Oct 16, 2024
pulisher
Oct 16, 2024

Short Interest in Keros Therapeutics, Inc. (NASDAQ:KROS) Declines By 13.7% - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Objective long/short (KROS) Report - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 09, 2024

Renaissance Technologies LLC Invests $654,000 in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Oct 09, 2024
pulisher
Oct 09, 2024

Renaissance Technologies LLC Acquires New Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Marshall Wace LLP Has $1.02 Million Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Dimensional Fund Advisors LP Sells 3,691 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Oct 08, 2024
pulisher
Oct 07, 2024

19,832 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Bought by Squarepoint Ops LLC - Defense World

Oct 07, 2024
pulisher
Oct 07, 2024

Squarepoint Ops LLC Buys New Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Oct 07, 2024

Keros Therapeutics Inc (KROS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):